Loading…

Integrated pathway analysis of malignant rhabdoid tumour identifies key SMARCB1-pathways and therapeutic opportunities

An abstract of a study by Finetti et al assessing integrated pathway analysis of malignant rhabdoid tumour (MRTs) identifies key SMARCB1-pathways and therapeutic opportunities is presented. Integrated network-based pathway analysis identifies several key SMARCB1-dependent and potentially druggable g...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2016-12, Vol.69, p.S51-S51
Main Authors: Finetti, M.A, Selby, M.P, Del Carpio Pons, A, Wong, J.P, Bashton, M, Cranston, R.E, Barker, J, Crosier, S, Smith, A, Ramli, R.A, Grabovska, Y, Bailey, S, Huang, P.H, Clifford, S.C, Williamson, D
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An abstract of a study by Finetti et al assessing integrated pathway analysis of malignant rhabdoid tumour (MRTs) identifies key SMARCB1-pathways and therapeutic opportunities is presented. Integrated network-based pathway analysis identifies several key SMARCB1-dependent and potentially druggable genes/pathways deregulated at the transcriptional/methylation level in primary MRTs.
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(16)32736-8